Stepping up our game with secondary immune deficiency

Pharmacologic immune suppression in the past was dirty. I imagine many readers of this journal remember days when systemic corticosteroids were pretty much the only medication they had to effectively treat asthma and rheumatologic diseases. Fortunately, as the management of inflammatory and autoimmune conditions has been refined over the past few decades, our reliance on broad immune suppressants has decreased. Although we still have our “old faithful” prednisone to fall back on, we can now use more targeted therapies to improve outcomes.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Editorial Source Type: research